mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

Clinical trial NCT07062536 · RECRUITING

Trial details

NCT number: NCT07062536
Sponsor: Seoul National University Bundang Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Cancer Metastatic

Start date: 2025-08-27
Primary completion: 2027-04-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.